AGI-5198,
AGI-5198,
1355326-35-0,
IDH-C35,
AGI-5198(IDH C35),
CHEMBL2180727,
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-o-tolylacetamide,
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamido)-2-(o-tolyl)acetamide,
N-cyclohexyl-2-(3-fluoro-N-[2-(2-methylimidazol-1-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide,
AGI-5198 (IDH-C35),
MLS006010252,
GTPL9240,
SCHEMBL15118942,
C27H31FN4O2,
AGI5198,
AOB5947,
DTXSID30718166,
EX-A171,
QCR-214,
HMS3653K15,
AGI 5198,
BCP07382,
BDBM50400272,
MFCD24848688,
s7185,
AKOS026674117,
CS-1429,
SB19576,
KS-0000000N,
NCGC00347934-01,
NCGC00347934-09,
4CA-0126,
AK198943,
BC600444,
HY-18082,
SMR004701328,
AB0032505,
FT-0768624,
SW220036-1,
X5817,
W-6035,
S900006220,
N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-(2-methyl-1H-imidazol-1-yl)acetamide,
FNYGWXSATBUBER-UHFFFAOYSA-N,
A4339,
C581156,